↓ Skip to main content

Ustekinumab is effective in biological refractory Crohn’s disease patients–regardless of approval study selection criteria

Overview of attention for article published in Intestinal Research , May 2019
Altmetric Badge

Readers on

mendeley
21 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Ustekinumab is effective in biological refractory Crohn’s disease patients–regardless of approval study selection criteria
Published in
Intestinal Research , May 2019
DOI 10.5217/ir.2019.00012
Pubmed ID
Authors

Sadik Saman, Martin Goetz, Judith Wendler, Nisar P. Malek, Jan Wehkamp, Thomas Klag

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 21 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 21 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 5 24%
Student > Bachelor 3 14%
Student > Doctoral Student 2 10%
Student > Ph. D. Student 2 10%
Professor 2 10%
Other 2 10%
Unknown 5 24%
Readers by discipline Count As %
Medicine and Dentistry 10 48%
Agricultural and Biological Sciences 2 10%
Computer Science 1 5%
Pharmacology, Toxicology and Pharmaceutical Science 1 5%
Economics, Econometrics and Finance 1 5%
Other 1 5%
Unknown 5 24%